Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyoshi Harashima

Showing results (81-90 of 496) with videos related to

Pageof 50
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2017
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytesKazuki Hashiba, Yusuke Sato, Hideyoshi Harashima
Nucleic Acids Research. Supplement (2001)|September 27, 2003
Mutations induced by 2-hydroxy-dATP during in vitro replication with a HeLa extractKazuya Satou, Hideyoshi Harashima, Hiroyuki Kamiya
Biological & Pharmaceutical Bulletin|August 2, 2011
A20 silencing by lipid envelope-type nanoparticles enhances the efficiency of lipopolysaccharide-activated dendritic cellsShota Warashina, Takashi Nakamura, Hideyoshi Harashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 4, 2006
[Envelope-type nano device for gene delivery]Kentaro Kogure, Hidetaka Akita, Hideyoshi Harashima
FEBS Letters|January 24, 2006
Intranuclear disposition of exogenous DNA in vivo: silencing, methylation and fragmentationHiroshi Ochiai, Hideyoshi Harashima, Hiroyuki Kamiya
The Journal of Gene Medicine|November 3, 2004
Increased SFHR gene correction efficiency with sense single-stranded DNAHiroyuki Tsuchiya, Hideyoshi Harashima, Hiroyuki Kamiya
International Journal of Pharmaceutics|November 20, 2009
Intracellular fate of octaarginine-modified liposomes in polarized MDCK cellsTakahiro Fujiwara, Hidetaka Akita, Hideyoshi Harashima
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial CellsYu Sakurai, Tomoya Hada, Hideyoshi Harashima
International Journal of Pharmaceutics|November 12, 2017
Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorptionShoshiro Yamamoto, Yu Sakurai, Hideyoshi Harashima
International Journal of Nanomedicine|December 28, 2018
Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targetingNour Shobaki, Yusuke Sato, Hideyoshi Harashima
Pageof 50

Showing results (81-90 of 496) with videos related to

Sort By:
Pageof 50
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2017
pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytesKazuki Hashiba, Yusuke Sato, Hideyoshi Harashima
Nucleic Acids Research. Supplement (2001)|September 27, 2003
Mutations induced by 2-hydroxy-dATP during in vitro replication with a HeLa extractKazuya Satou, Hideyoshi Harashima, Hiroyuki Kamiya
Biological & Pharmaceutical Bulletin|August 2, 2011
A20 silencing by lipid envelope-type nanoparticles enhances the efficiency of lipopolysaccharide-activated dendritic cellsShota Warashina, Takashi Nakamura, Hideyoshi Harashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 4, 2006
[Envelope-type nano device for gene delivery]Kentaro Kogure, Hidetaka Akita, Hideyoshi Harashima
FEBS Letters|January 24, 2006
Intranuclear disposition of exogenous DNA in vivo: silencing, methylation and fragmentationHiroshi Ochiai, Hideyoshi Harashima, Hiroyuki Kamiya
The Journal of Gene Medicine|November 3, 2004
Increased SFHR gene correction efficiency with sense single-stranded DNAHiroyuki Tsuchiya, Hideyoshi Harashima, Hiroyuki Kamiya
International Journal of Pharmaceutics|November 20, 2009
Intracellular fate of octaarginine-modified liposomes in polarized MDCK cellsTakahiro Fujiwara, Hidetaka Akita, Hideyoshi Harashima
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2015
Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial CellsYu Sakurai, Tomoya Hada, Hideyoshi Harashima
International Journal of Pharmaceutics|November 12, 2017
Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorptionShoshiro Yamamoto, Yu Sakurai, Hideyoshi Harashima
International Journal of Nanomedicine|December 28, 2018
Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targetingNour Shobaki, Yusuke Sato, Hideyoshi Harashima
Pageof 50